TrialSignal
Clinical trial intelligence report
Expression of D2-Like Dopamine Receptor of Human Aldosterone-Producing Adenoma and Its Role in Regulation of Aldosterone Secretion and Cell Proliferation
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jul 28, 2026
Report code
NCT00173446-Jul 28, 2026
NCT ID
NCT00173446
Status
UNKNOWN
Phase
registry-stage
Sponsor
National Taiwan University Hospital
Executive brief
Investment-Ready Snapshot
Expression of D2-Like Dopamine Receptor of Human Aldosterone-Producing Adenoma and Its Role in Regulation of Aldosterone Secretion and Cell Proliferation is a registry-stage clinical asset sponsored by National Taiwan University Hospital in Hypertension, Adrenal Aldosterone-Producing Adenoma. SEO and diligence focus: mRNA, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT00173446
Indication
Hypertension
Modality
RNA therapy
Target
mRNA
Intervention
Not reported
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.